BDX bcal diagnostics limited

0.00%

6.9¢

Ann: Investor Presentation, page-7

First 7 Last

Share
Profile

Follow
Rorbag

2,237 Posts.

448

26/03/25

13:58

Post #: 78423371
Share

Originally posted by bigbullasx: ↑

The test is designed to rule out cancer, so its 91% sensitivity is the key performance measure. However, due to its low specificity—it isn’t effective for confirming cancer—it must be used alongside mammography.

Galleri test will give you insights why this BREASTEST plus rule out cancer test is important.

Now, the Australian market opportunitues (conservative approach):

In Australia, there are 1.8 million screenings annually.
Approximately 40% of these screenings involve women with high-density breasts (despite BCAL's internal estimate of 50%, Vicki Durston from the Breast Cancer Network reported 40% in the 7 News report).
Of those, about 10% require further investigation.

This means the target market is 10% of 40% of 1.8 million, which equals 72,000 tests [10 % of (40% of 1.8 million) = 10% of 720,000 = 72,000 tests].
Lets assume, BCAL captures roughly 25% of that market—about 18,000 tests [25% of 72,000 = 18,000 tests]
—translating to an annual revenue of approximately AUD 5.4 million (18,000 tests × AUD 300 per test).

Expand

Thata fair enough but why the drop from 85% to 49% specificity in 2 years? Are you saying specificity % should be disregarded? I believe FDA have a cut off at 51%.

BDX Price at posting: 11.0¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

PTX

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 6.9¢		Change 0.000(0.00%)		Mkt cap ! $25.25M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	3024	6.6¢

Sellers (Offers)

Price($)	Vol.	No.
7.2¢	171972	2

View Market Depth

No.	Vol.	Price($)
1	3024	0.066
3	67352	0.065
2	104766	0.064
1	79365	0.063
1	17591	0.062

Price($)	Vol.	No.
0.072	167698	1
0.073	95048	1
0.075	682945	1
0.080	70000	1
0.084	11764	1

Last trade - 10.05am 22/07/2025 (20 minute delay)

BDX (ASX) Chart

Day chart unavailable

Ann: Investor Presentation, page-7

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Investor Presentation, page-7

Top Stories

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News